|
Market Cap (1-Jul) $2,324,063,488 (333rd) |
Close (30-Jun) $1.14 |
Volume (30-Jun) 2,606,681 |
Shortsold (19-Jun) 79,324,475 (6.21%) (26th) |
|
52w High $3.37 |
52w Low $0.88 |
P/E 454.55 |
EPS -0.13 |
MSB released this announcement to the ASX on 24 October 2022, 9:51. The announcement is not marked as price sensitive, and is 240 page(s) in length and 6.59MB in size.
You can view all announcements from MSB and see how they appear on a price chart on the announcements page.
At the date of this announcement, MSB was 3.801% short sold according to ASIC data. It was ranked the 68th most shorted stock on the ASX. It is now ranked as the 26th most shorted stock on the ASX with 6.208% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from MSB | |
|---|---|
| Change of Director's Interest Notice | 13 June 2023, 8:56 |
| Mesoblast Director Appointed to Strategic Advisory Role | 5 June 2023, 9:41 |
| MSB Reports Q3 Financial Results and Operational Highlights | 26 May 2023, 8:32 |
| Annual Report to Shareholders | 24 October 2022, 9:51 |
| Appendix 4G and Corporate Governance Statement | 24 October 2022, 9:39 |
| Notification of cessation of securities - MSB | 14 October 2022, 17:49 |
| Submits New Information to FDA IND File for SR-aGVHD | 3 October 2022, 9:49 |
You must be logged in to post a reply.
Mesoblast 